Mycyclame (Drospirenone, Ethinylestradiol | Lactose)

Drospirenone/Ethinylestradiol, the active ingredient in Mycyclame, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. GNH USA supplies Mycyclame as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mycyclame, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent unintended pregnancy. - Contraception: prevention of pregnancy in women of child‑bearing potential. - Menstrual cycle regulation: helps achieve predictable, regular periods. - Acne management: may improve mild to moderate acne associated with hormonal fluctuations.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: transient swelling or discomfort. - Headache: occasional mild to moderate pain. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight gain: modest increase in body weight. - Mood changes: irritability or mood swings.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Myocardial infarction: heart attack risk, especially in smokers. - Severe hypertension: sudden rise in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Mycyclame, consider the following safety measures. - Contraindications: avoid in patients with a history of thromboembolic disorders or clotting disorders. - Smoking: do not use in women who smoke >15 cigarettes per day, especially over age 35. - Liver disease: caution in patients with active liver disease or impaired hepatic function. - Hypertension: monitor blood pressure regularly; avoid in uncontrolled hypertension. - Pregnancy: not indicated for use during pregnancy; discontinue if pregnancy occurs. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mycyclame may interact with several medicines that affect its efficacy or safety. Major Interactions (Avoid): - CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin) – may reduce contraceptive effect. - St. John’s wort – can decrease hormone levels, risking breakthrough bleeding. - Protease inhibitors (e.g., ritonavir) – may increase hormone concentrations. - Certain anticonvulsants – may lower effectiveness of contraception. - Antimicrobial agents (e.g., griseofulvin) – can diminish hormonal activity.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole) – may increase hormone levels, watch for side effects. - SSRIs (e.g., fluoxetine) – potential for altered metabolism. - Diuretics – may affect fluid balance and blood pressure. - Antihypertensives (e.g., ACE inhibitors) – monitor blood pressure changes. - Lithium – may increase lithium levels; monitor serum concentrations.